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This series of reports presents an early assessment of the extent of COVID-19-related 
impact on childhood vaccinations based on vaccine coverage data for dose 1, 2 and 3 
Hexavalent and dose 1 MMR vaccines extracted from ImmForm. 
 
This is the twentieth report and includes vaccine coverage data up to the end of June 
2021. 
 
Early vaccine coverage 
Early vaccine coverage data uploaded on ImmForm is extracted at 6 months of age to 
assess vaccine coverage for Hexavalent vaccine doses 1 to 3, and at 18 months to 
assess vaccine coverage for MMR1. Vaccine coverage data extracted from ImmForm up 
to and including June 2021 indicates that: 
 
• 87.8% of infants completed the 3-dose course of Hexavalent vaccine by 6 months of 
age – this is 1.0 percentage point lower compared to June 2019 but 2.5 percentage 
points higher compared to June 2020  
• in June 2021, 87.0% of infants were vaccinated with MMR1 by 18 months of age – 
this is 0.9 and 0.3 percentage points lower than June 2019 and June 2020, 
respectively. The WHO coverage target for MMR1 is 95% coverage by 24 months 
 
All children who have missed out on their routine vaccinations during the coronavirus 
(COVID-19) pandemic remain eligible for their vaccines. As physical distancing and 
lockdown measures change throughout the course of the pandemic, it is possible that 
there may be further impact on primary immunisations. It is therefore important for 
General Practitioners and local teams to continue offering routine immunisations, check 
that any infants or children impacted during the pandemic are rescheduled for their 
immunisation and, where required, consider implementing catch-up or recovery plans. 
 
Official vaccine coverage estimates for England reflecting coverage through the COVID-
19 pandemic will be assessed in the COVER (Cover of vaccination evaluated rapidly) 
programme when children reach their first, second, or fifth birthday [1]. 
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On 23 March 2020, in response to the COVID-19 pandemic, physical distancing 
measures were introduced in England which included school closures, stopping 
gatherings, non-essential use of public transportation and individuals being advised to 
work from home [2,3]. Advice from the Joint Committee on Vaccination and 
Immunisation (JCVI) on routine childhood immunisations stated that children should 
continue to receive vaccinations according to the national schedule throughout the 
lockdown [4].  
 
In England, childhood immunisations are offered according to the routine immunisation 
schedule [5]. Childhood vaccine coverage is routinely assessed in quarterly and annual 
COVER (Cover of vaccination evaluated rapidly) programme reports when children 
reach their first, second, or fifth birthdays [6,7]. The COVER reports display the official 
vaccine coverage estimates for England.  
 
Due to the timing of data extractions for the COVER collection, the full impact of COVID-
19 on primary immunisations is only known when children reach their first, second or 
fifth birthdays starting from Quarter 3 (financial year 2020 to 2021) of the COVER 
collection report. 
 
The purpose of this report therefore is to provide an early analysis using an alternative 
data source to assess the impact of COVID-19 on primary immunisations in England at 
a younger age than the COVER data.  
 
This report summarises vaccine coverage extracted up to June 2021 for dose 1, 2 and 3 
of Hexavalent vaccine at 6 months compared to coverage in 2019 and 2020, and 




This report is aimed for those who monitor and support the routine immunisation 
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The Hexavalent and MMR vaccines were selected for these analyses as a proxy for 
routine primary immunisations scheduled before 1 year of age and immunisations 
scheduled from 1 year of age, respectively, to provide an initial indication of the impact 
of COVID-19 on all primary immunisation programmes. 
 
Early monitoring vaccine coverage 
GP practice-level vaccine coverage data, automatically uploaded via participating GP IT 
suppliers to the ImmForm1 website on a monthly basis, was used to provide an early 
assessment of vaccine coverage for some of the routine childhood vaccinations. This 
data is validated and analysed by PHE to check data completeness, to identify and 
query any anomalous results, and to describe epidemiological trends. Vaccine coverage 
is calculated as the number of infants reaching a target age and receiving a vaccine(s) 
as a proportion of the total number of infants at the target age registered at the GP 
practice. 
 
Vaccine coverage estimates were extracted from ImmForm on a monthly basis for all 
children who reached 6 months or 18 months of age in that calendar month. Vaccine 
coverage estimates for Hexavalent vaccines 1, 2 and 3 were estimated when children 
reached 6 months of age, whilst vaccine coverage estimates for MMR1 were estimated 
when children reached 18 months of age. Vaccine coverage estimates for a different 
cohort of children were therefore extracted each month. To assess the potential impact 
of COVID-19, we compared vaccine coverage data extracted from ImmForm for 2019, 
2020 and 2021. Figure 1 shows the recommended scheduled timing of the Hexavalent 
dose 1, 2 and 3, and MMR1 vaccinations, and compares the timing of the ImmForm and 







1 ImmForm is the system used by Public Health England to record vaccine coverage data for some immunisation 
programmes and to provide vaccine ordering facilities for the NHS 
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Figure 1. Timeline from when infants are scheduled for their first, second and 
third dose of hexavalent vaccine and first dose of MMR vaccine and the time when 
ImmForm and CHIS data are extracted.  
 
Tables A1 and A2 (Appendix) show how ImmForm data extracted relate to the 
recommended schedule for Hexavalent and MMR1 vaccines. If COVID-19 had impacted 
vaccine delivery in a specific calendar month, this would be reflected in the Immform 
data in different months depending on the particular vaccines affected. For example, if 
COVID-19 had impacted vaccinations scheduled in April 2020, we would expect to see 
this reflected in the ImmForm data in June 2020 for Hexavalent dose 3, July 2020 for 
Hexavalent dose 2, August 2020 for Hexavalent dose 1 and October 2020 for MMR1 
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Early vaccine coverage assessment in England 
Monthly vaccine coverage data are available on ImmForm for at least 92% of general 




Early vaccine coverage estimates for 2020 and 2021 show there has been a decrease in 
vaccine coverage measured at 6 months of age for Hexavalent doses 1, 2 or 3, in every 
month since April 2020 when compared to 2019 (Table 1). The largest percentage 
decrease is seen in Hexavalent 3 vaccine, indicating fewer children have completed the 
full 3-vaccine course, though the percentage decrease has got smaller for all 3 doses 
since January 2021. 
 
Infants who were scheduled from 8 weeks of age for dose 1 Hexavalent vaccine in 
March 2020 onwards are reflected in the ImmForm vaccine coverage estimates at 6 
months of age from July 2020 onwards. Hexavalent 1 coverage trends for 2020 and 
2021 compared to 2019 are broadly similar but lower, with a large decrease of 0.8 
percentage points seen in the July 2020 data for infants scheduled to receive their first 
dose of Hexavalent vaccine in March 2020. Vaccine coverage was 0.2 percentage 
points lower in June 2021 compared to June 2019 and 0.2 percentage points lower 
compared to June 2020 (Figure 2).  
 
Infants scheduled from 12 weeks of age for dose 2 Hexavalent vaccine from March 2020 
onwards are reflected in June 2020 ImmForm coverage data onwards. Hexavalent 2 
coverage trends from the beginning of the pandemic in 2020 and throughout 2021 are 
broadly similar but remain lower than coverage in 2019. The largest decrease of 2.3 
percentage points compared to 2019 was observed in May 2020 (infants born in 
February 2020), which reflects children eligible for both their first and second dose of 
Hexavalent in the early months of the first lockdown. Vaccine coverage was 0.5 
percentage points lower in June 2021 compared to June 2019 and 1.5 percentage 
points higher compared to June 2020 (Figure 2, Table 1).  
 
Infants scheduled from 16 weeks of age for dose 3 Hexavalent vaccine from March 2020 
onwards are reflected in May 2020 ImmForm coverage data onwards. Vaccine coverage 
for dose 3 Hexavalent in May 2020 was substantially lower (5.5 percentage points) 
compared to coverage in May 2019, indicating that infants partially immunised and 
scheduled for their third dose of Hexavalent in March 2020 are likely to have been 
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impacted by COVID-19 restrictions. Vaccine coverage was 1.0 percentage points lower 
in June 2021 compared to June 2019 but was 2.5 percentage points higher compared to 
June 2020 (Figure 2, Table 1). 
 
Figure 2. Vaccine coverage for dose 1, 2 and 3 of the Hexavalent vaccine by 
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Table 1. Vaccine coverage for dose 1, 2 and 3 of the Hexavalent vaccine by survey month (extracted at 6-month age 
cohorts) in 2019, 2020 and 2021 
 
Month  




















































Jan 96.1 96.2 0.1 95.6 -0.5* -0.6* 93.5 93.7 0.3 92.3 -1.2* -1.4* 87.7 88.5 0.8 85.4 -2.3* -3.1* 
Feb 95.9 96.3 0.4 95.6 -0.3* -0.7* 93.1 93.8 0.7 92.3 -0.8* -1.5* 87.2 88.4 1.2 85.5 -1.7* -2.9* 
Mar 96.0 96.6 0.6 95.8 -0.2* -0.8* 93.4 94.0 0.5 92.9 -0.5* -1.1* 88.1 88.6 0.5 87.3 -0.8* -1.3* 
Apr 96.2 95.9 -0.3 95.9 -0.3* 0.0* 93.9 92.4 -1.5 93.3 -0.6* 0.9* 88.8 84.1 -4.7 87.9 -0.9* 3.8* 
May 96.5 96.0 -0.5 95.7 -0.8* -0.3* 94.3 92.0 -2.3 93.3 -1.0* 1.2* 89.4 83.9 -5.5* 87.7 -1.8* 3.8* 
Jun 96.2 95.8 -0.4 96.0 -0.2* 0.2* 93.9 91.9 -2.0* 93.4 -0.5* 1.5* 88.8 85.3 -3.5* 87.8 -1.0* 2.5* 
Jul 96.4 95.6 -0.8*    94.0 92.4 -1.6*    89.1 86.5 -2.7*    
Aug 96.3 95.9 -0.4*    94.0 93.3 -0.7*    89.0 87.6 -1.4*    
Sep 96.4 96.0 -0.4*    93.9 93.3 -0.6*    88.9 87.1 -1.8*    
Oct 96.2 95.9 -0.3*    93.9 93.0 -0.9*    89.2 86.3 -3.0*    
Nov 96.1 95.5 -0.6*    93.6 92.5 -1.1*    88.7 85.8 -2.9*    
Dec 96.2 95.7 -0.6*    93.7 92.5 -1.3*    88.1 85.4 -2.7*    
 
* Indicates cohorts of infants scheduled to receive their vaccine from March 2020 onwards 
Impact of COVID-19 on routine childhood immunisations: early vaccine coverage data to June 2021 (England)  




MMR1 monthly vaccine coverage estimates measured at 18 months of age from 2019 to 
2021, show a monthly decrease from April 2020 onwards. In June 2021, 87.0% of 
infants were vaccinated with MMR1 at 18 months of age (Table 2, Figure 3). 
 
The largest decreases of 2.0 to 2.1 percentage points compared to 2019 was observed 
in August to November 2020 which reflects children eligible for their first MMR vaccine in 
the early months of the first lockdown. Vaccine coverage was 0.9 percentage points 
lower in June 2021 compared to June 2019 and 0.3 percentage points lower than 
coverage in 2020 (Table 2, Figure 3).  
 
In 2019, 2020 and 2021, MMR1 coverage is substantially below the WHO target of 95% 
coverage at 24 months.  
 
Table 2. Vaccine coverage for dose 1 of the MMR vaccine by survey month 
(extracted at 18-month age cohorts) in 2019, 2020 and 2021 
 
 MMR dose 1 (%)  
Survey 




















Jan 87.3 88.1 0.8 85.9 -1.4* -2.2* 
Feb 87.2 88.3 1.0 86.0 -1.2* -2.3* 
Mar 87.2 88.2 1.0 86.4 -0.8* -1.8* 
Apr 87.8 87.6 -0.2 86.7 -1.1* -0.9* 
May 88.2 87.9 -0.3 86.4 -1.7* -1.5* 
Jun 87.8 87.3 -0.5 87.0 -0.9* -0.3* 
Jul 88.2 87.1 -1.1    
Aug 88.6 86.5 -2.1    
Sep 88.4 86.4 -2.0*    
Oct 88.6 86.5 -2.1*    
Nov 88.4 86.3 -2.1*    
Dec 88.1 86.2 -1.9*    
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Figure 3. Vaccine coverage for MMR1 at 18 months of age by survey month in 
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This report presents an early indication of the impact of COVID-19 on routine childhood 
immunisations in England, using early vaccine coverage data. The purpose of the report 
is to provide early coverage estimates to those who monitor and support the routine 
immunisation programme at both a local and national level. Early assessment of age-
specific vaccine coverage allows local areas to assess performance before children 
reach the age that formal vaccine coverage is evaluated by the COVER programme, 
therefore giving local teams an opportunity to catch-up where shortfalls have been 
identified. 
 
The vaccine coverage data has pointed towards a sustained decrease in children 
receiving routine childhood immunisations in 2020 and 2021 compared to 2019. Since 
April 2020, fewer infants have completed the full course of 3 Hexavalent vaccines by 6 
months of age, and fewer children have received MMR1 by 18 months of age. The initial 
decrease in vaccination may be associated with COVID-19 messaging about staying 
home initially, overwhelming the messaging that the routine immunisation programme 
was to remain operating as usual [2,4,10]. Additionally, anecdotal information indicated 
that in some areas, to ensure safe and best practice, GPs had to reschedule 
appointments in the initial weeks to ensure social distancing within GP practices. 
Overall, decreased vaccination coverage compared to 2019 levels has continued 
throughout the pandemic, though the size of the decrease in vaccine coverage is 
increasingly smaller from January 2021 onwards. 
 
Early monthly assessment of completed courses (3 doses) of Hexavalent vaccines in 
June 2021, measured at 6 months, was at 87.8%. This is lower than the 95% WHO 
target for the full course of 3 Hexavalent vaccines at 5 years [11]. Dose 3 Hexavalent 
vaccine coverage was 1.0 percentage points lower in June 2021 compared to June 2019 
but was 2.5 percentage points higher compared to June 2020. Early monthly 
assessment of MMR1 coverage for June 2021 measured at 18 months of age is at 
87.0% and falls short of the WHO target of 95% coverage by 24 months of age [11]. 
MMR1 18-month coverage was 0.9 and 0.3 percentage points lower in June 2021 than 
in June 2019 and June 2020, respectively. Coverage will continue to be closely 
monitored for both vaccines in the upcoming months. 
 
The most recent quarterly COVER report evaluated vaccine coverage for children who 
reached their first, second or fifth birthday from January to March 2021. Vaccine 
coverage for children turning 12 months old during the fourth quarterly COVER 
evaluation report (born January to March 2020) reflects infants who were scheduled to 
receive their first dose of Hexavalent vaccine during the first national lockdown (from 
March to May 2020). Vaccine coverage for a completed course of the 3 Hexavalent 
vaccines at 12 months old in Quarter 4 2020 to 2021 was 1.1 percentage point lower 
than coverage during the same quarter in 2019 to 2020. Furthermore, among children 
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who were born between January and March 2019 and were scheduled to receive their 
first dose of MMR from January to March 2020, when lockdown initiated, a 1.5 
percentage point decrease in MMR1 at 24 months was observed in the COVER 
Quarter 4 report compared to Quarter 4 2019 to 2020. Children scheduled to receive 
their vaccines in March 2020 onwards, or those who were late booking their appointment 
and ordinarily would have caught up by their first or second birthday may have been 
impacted by social distancing and lockdown measures from late March 2020 onwards. 
This may be a contributing factor to the observed decreases in coverage seen in this 
quarter [1,6,8]. 
 
Strengths and limitations 
This analysis of early vaccine coverage for children before they reach the target ages of 
12 and 24 months used for routine surveillance systems provides a timelier assessment 
of the impact of COVID-19 on primary immunisations in England. The report helps 
monitor national level vaccine coverage throughout the pandemic. 
 
Vaccine coverage estimates from ImmForm show early estimates of vaccine coverage. 
This data allows for local performance management where areas can assess which 
cohorts may require further follow-up for vaccination.  
 
Vaccine coverage estimates are extracted by GP IT suppliers, based on a set list of 
SNOMED CT codes, therefore these estimates only reflect coverage for children 
registered with a GP practice, and that have correct coding in their GP record. 
Furthermore, the ImmForm data is experimental data and to date has only been used for 
performance management purposes – it is not validated at the GP practice level. 
Smaller areas may see greater differences in coverage due to smaller numbers. 
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Future monthly ImmForm collections will continue to monitor any impact of COVID-19 on 
early vaccine coverage. Vaccine coverage will vary across the country and local areas 
can monitor early estimates of coverage in their areas using ImmForm and other data 
sources to identify areas needing more support. 
 
As physical distancing measures change throughout the course of the pandemic and the 
risk of other infectious diseases circulating increases it is of utmost importance that GPs 
continue offering routine immunisations, check and recall those who have not received a 
vaccine and, where required, recovery plans should be set in place to address any drop 
in vaccine coverage observed since the beginning of the pandemic. 
 
Local areas should engage with specific cohorts of infants and children who may have 
been affected when social distancing measures were introduced, to ensure that they are 
rescheduled for their immunisations [12]. These children will remain eligible and will be 
assessed in the appropriate age-specific routine quarterly coverage estimates in the 
COVER publication.  
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Table A1. Monthly data extracts from ImmForm survey for Hexavalent vaccine, 
showing month of birth and the month vaccine is first due. 
 
Hexavalent vaccine 








Month vaccine first due 
   Dose 1 
(8 weeks old) 
Dose 2 
(12 weeks old) 
Dose 3 
(16 weeks old) 
Jan 2020 6 months Jul 2019 Sep 2019 Oct 2019 Nov 2019 
Feb 2020 6 months Aug 2019 Oct 2019 Nov 2019 Dec 2019 
Mar 2020 6 months Sep 2019 Nov 2019 Dec 2019 Jan 2020 
Apr 2020 6 months Oct 2019 Dec 2019 Jan 2020 Feb 2020 
May 2020 6 months Nov 2019 Jan 2020 Feb 2020 Mar 2020 
Jun 2020 6 months Dec 2019 Feb 2020 Mar 2020 Apr 2020 
Jul 2020 6 months Jan 2020 Mar 2020 Apr 2020 May 2020 
Aug 2020 6 months Feb 2020 Apr 2020 May 2020 Jun 2020 
Sep 2020 6 months Mar 2020 May 2020 Jun 2020 Jul 2020 
Oct 2020 6 months Apr 2020 Jun 2020 Jul 2020 Aug 2020 
Nov 2020 6 months May 2020 Jul 2020 Aug 2020 Sep 2020 
Dec 2020 6 months Jun 2020 Aug 2020 Sep 2020 Oct 2020 
Jan 2021 6 months Jul 2020 Sep 2020 Oct 2020 Nov 2020 
Feb 2021 6 months Aug 2020 Oct 2020 Nov 2020 Dec 2020 
Mar 2021 6 months Sep 2020 Nov 2020 Dec 2020 Jan 2021 
Apr 2021 6 months Oct 2020 Dec 2020 Jan 2021 Feb 2021 
May 2021 6 months Nov 2020 Jan 2021 Feb 2021 Mar 2021 
June 2021 6 months Dec 2020 Feb 2021 Mar 2021 Apr 2021 
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Table A2. Monthly data extracts from ImmForm survey for MMR1 vaccine, 
showing month of birth and the month vaccine is first due. 
 
MMR1 
Month data is extracted 
from ImmForm 
Age at which data 
is extracted 
Month of birth Month vaccine 
first due 
Jan 2020 18 months Jul 2018 Jul 2019 
Feb 2020 18 months Aug 2018 Aug 2019 
Mar 2020 18 months Sep 2018 Sep 2019 
Apr 2020 18 months Oct 2018 Oct 2019 
May 2020 18 months Nov 2018 Nov 2019 
Jun 2020 18 months Dec 2018 Dec 2019 
Jul 2020 18 months Jan 2019 Jan 2020 
Aug 2020 18 months Feb 2019 Feb 2020 
Sep 2020 18 months Mar 2019 Mar 2020 
Oct 2020 18 months Apr 2019 Apr 2020 
Nov 2020 18 months May 2019 May 2020 
Dec 2020 18 months Jun 2019 Jun 2020 
Jan 2021 18 months Jul 2019 Jul 2020 
Feb 2021 18 months Aug 2019 Aug 2020 
Mar 2021 18 months Sep 2019 Sep 2020 
Apr 2021 18 months Oct 2019 Oct 2020 
May 2021 18 months Nov 2019 Nov 2020 
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